GSK Investigational Site

Clichy 92118

0 studies enrolling now · 10 studies all time

What they study most

Chronic Hepatitis B, Chronic Hepatitis B Virus Infection, Crohn's Disease, Hepatitis B, Hepatitis B, Chronic, Hepatitis C, Hepatitis C, Chronic, Purpura, Thrombocytopaenic, Idiopathic, Thrombocytopenia

Studies at this site

• Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) — Completed
• A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) — Running, not enrolling
• Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) — Running, not enrolling
• A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) — Completed
• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• LENS - Long-term Eltrombopag Observational Study — Completed
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C — Completed